Delta, Lambda COVID Variants Still Weighing On Market Despite Positive Earnings Reports
The market is still in a waiting mode, with a lot hinging on tomorrow’s jobs report.
Cigna: Q2 Earnings Insights
Shares of Cigna (NYSE:CI) were unchanged after the company reported Q2 results.
Quarterly Results
Earnings per share were down 9.81% year over year to $5.24, which beat the estimate of $4.96.
Cigna Strongly Beats On Q2 Earnings; Raises FY21 Sales Outlook, Expects Higher Unfavorable COVID-19 Impact
Cigna Corp (NYSE:CI) reports Q2 total revenues of $43.1 billion, +9.8% Y/Y, ahead of the consensus of $41.31 billion. Q2 adjusted…
Cigna Q2 Adj. EPS $5.24 Beats $4.96 Estimate, Sales $43.10B Beat $41.31B Estimate
Cigna (NYSE:CI) reported quarterly earnings of $5.24 per share which beat the analyst consensus estimate of $4.96 by 5.65 percent. This is a 9.81 percent decrease over earnings of $5.81 per share from the same period
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
Another Big Earnings Week Ahead
After a monumental week of Big Tech earnings, we're in for more than a quarter of S&P 500 companies' reports, including those from Alibaba (NYSE: BABA), General Motors (NYSE: GM), and Kraft Heinz
Biogen’s Costly Alzheimer’s Treatment May Face Restricted Medicare Access: WSJ
The recent approval of Biogen Inc’s (NASDAQ:BIIB) high-price Alzheimer’s drug is raising questions about who will have access to the $56,000/year treatment…
Morgan Stanley Maintains Overweight on Cigna, Raises Price Target to $321
Morgan Stanley analyst Ricky Goldwasser maintains Cigna (NYSE:CI) with a Overweight and raises the price target from $254 to $321.